Modified-IL-2 (VIS171) to Preferentially Induce Regulatory T Cells in Nonhuman Primates
September 6, 2024 | Promise of Interleukin-2 Therapy Conference
John J. O’Neil, Davide Schiliró, Joe M. Ladowski, Janghoon Yoon, Angela Park, Rafaela Belloni, Asher D. Schachter, David Oldach, Gregory J. Babcock, Jean Kwun, Stuart Knechtle